BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	163,098.19 607.60M	-0.87% -1432.62
ALLSHR	99,276.25 1,397.26M	-0.80% -801.63
KSE30	50,184.56 221.88M	-0.89% -450.56
KMI30	238,333.52 129.55M	-1.13% -2718.46
KMIALLSHR	65,792.54 685.73M	-0.99% -655.65
BKTi	45,653.52 111.72M	-1.00% -461.31
OGTi	32,313.25 10.70M	-1.57% -516.41

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	114,520.00	0.00 0.00	-2470.00 -2.11%
BRENT CRUDE	62.09	65.36 62.00	-3.13 -4.80%
RICHARDS BAY COAL MONTHLY	81.00	81.00 81.00	-1.60 -1.94%
ROTTERDAM COAL MONTHLY	90.50	0.00 0.00	0.40 0.44%
USD RBD PALM OLEIN	1,085.00	1,085.00 1,085.00	0.00 0.00%
CRUDE OIL - WTI	58.24	0.00 0.00	-0.66 -1.12%
SUGAR #11 WORLD	16.10	16.35 15.97	-0.16 -0.98%